These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10052752)

  • 1. Immune clearance of HIV type 1 replication-active cells: a model of two patterns of steady state HIV infection.
    Bucy RP
    AIDS Res Hum Retroviruses; 1999 Feb; 15(3):223-7. PubMed ID: 10052752
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-1 and immune control: can we change the course of HIV-1?
    Kovacs A; Connors M
    Lancet; 2004 Mar; 363(9412):833-4. PubMed ID: 15031022
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV-1 evolution and disease progression.
    Nowak MA; Anderson RM; Boerlijst MC; Bonhoeffer S; May RM; McMichael AJ
    Science; 1996 Nov; 274(5289):1008-11. PubMed ID: 8966557
    [No Abstract]   [Full Text] [Related]  

  • 4. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
    McNeil AC; Shupert WL; Iyasere CA; Hallahan CW; Mican JA; Davey RT; Connors M
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13878-83. PubMed ID: 11717444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune activation and the pathogenesis of HIV disease: implications for therapy.
    Fernandez S; Lim A; French M
    J HIV Ther; 2009 Nov; 14(3):52-6. PubMed ID: 20218239
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of HIV-1 replication by HIV-1-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-1-infected cells in vitro.
    Liu H; Ohashi T; Masuda T; Zhou X; Kubo M; Kannagi M
    Viral Immunol; 2003; 16(3):381-93. PubMed ID: 14583152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward HIV eradication or remission: the tasks ahead.
    Ho DD
    Science; 1998 Jun; 280(5371):1866-7. PubMed ID: 9669944
    [No Abstract]   [Full Text] [Related]  

  • 8. CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication.
    Yang OO; Walker BD
    Adv Immunol; 1997; 66():273-311. PubMed ID: 9328644
    [No Abstract]   [Full Text] [Related]  

  • 9. The moving target: mechanisms of HIV persistence during primary infection.
    Soudeyns H; Pantaleo G
    Immunol Today; 1999 Oct; 20(10):446-50. PubMed ID: 10500291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS pathogenesis: a finite immune response to blame?
    Miedema F; Klein MR
    Science; 1996 Apr; 272(5261):505-6. PubMed ID: 8614796
    [No Abstract]   [Full Text] [Related]  

  • 11. A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection.
    Maenetje P; Riou C; Casazza JP; Ambrozak D; Hill B; Gray G; Koup RA; de Bruyn G; Gray CM
    J Immunol; 2010 May; 184(9):4926-35. PubMed ID: 20363974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elite suppression of HIV-1 replication.
    Blankson JN; Siliciano RF
    Immunity; 2008 Dec; 29(6):845-7. PubMed ID: 19100698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.
    Blankson JN; Gallant JE; Siliciano RF
    J Infect Dis; 2001 Feb; 183(4):657-61. PubMed ID: 11170994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
    Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
    Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How resting T cells deMURR HIV infection.
    Greene WC
    Nat Immunol; 2004 Jan; 5(1):18-9. PubMed ID: 14699403
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs.
    Bailey J; Blankson JN; Wind-Rotolo M; Siliciano RF
    Curr Opin Immunol; 2004 Aug; 16(4):470-6. PubMed ID: 15245741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-specific CD4+ T cells and viremia: who's in control?
    Jansen CA; van Baarle D; Miedema F
    Trends Immunol; 2006 Mar; 27(3):119-24. PubMed ID: 16458605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
    Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latently infected cell activation: a way to reduce the size of the HIV reservoir?
    Forde J; Volpe JM; Ciupe SM
    Bull Math Biol; 2012 Jul; 74(7):1651-72. PubMed ID: 22562387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.
    Rivière Y
    Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():45-8. PubMed ID: 7950861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.